Indical acquires Afosa to expand into the companion animal sector

November 24, 2020

Indical has acquired Afosa GmbH, a leading provider of ELISA diagnostics products to the companion animal sector, based in Germany.

Indical has a strong diagnostics portfolio focused on production animals, which is built on more than twenty years of research and development of molecular and immunological testing solutions. Through the acquisition of Afosa, Indical broadens its product offering to also include a number of diagnostic kits for companion animals.

Recent news

First day of trading in Vimian’s shares on …

Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, today announces the listing of and commencement

Read more

Vimian announces intention to list on Nasdaq Firs…

Vimian Group AB (publ), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, announces its intention to carry out a private placement of shares in the

Read more

Fidelio forms Vimian – a global powerhouse …

Following a decade of successfully shaping market leaders across the rapidly evolving animal health market, Fidelio Capital AB (Fidelio) today announced the formation of Vimian – a global and diversified group of innovation-driven companies operating in four fast-growing animal health

Read more